IMNM - Immunome  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMNM is currently covered by 3 analysts with an average price target of $16.92. This is a potential upside of $10.99 (185.33%) from yesterday's end of day stock price of $5.93.

Immunome 's activity chart (see below) currently has 8 price targets and 15 ratings on display. The stock rating distribution of IMNM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.67% with an average time for these price targets to be met of 87.4 days.

Highest price target for IMNM is $33, Lowest price target is $21, average price target is $26.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 20-Mar-2025. First documented stock forecast 20-Aug-2021.

Best performing analysts who are covering IMNM - Immunome :

Matthew Barcus David Nierengarten Brian Cheng Geulah Livshits Biren Amin

Currently out of the existing stock ratings of IMNM, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$33

$27.07 (456.49%)

$33

17 days ago
(20-Mar-2025)

2/6 (33.33%)

$24.34 (281.06%)

14

Buy

$21

$15.07 (254.13%)

$23

4 months 23 days ago
(14-Nov-2024)

0/3 (0%)

$9.86 (88.51%)

Buy

$24

$18.07 (304.72%)

$33

11 months 7 days ago
(30-Apr-2024)

0/3 (0%)

$9.94 (70.70%)

Buy

$8

$2.07 (34.91%)

$9

2 years 20 days ago
(17-Mar-2023)

3/3 (100%)

$2.31 (40.60%)

398

Buy

$21

$12.65 (151.50%)

3 years 7 months 17 days ago
(20-Aug-2021)

1/1 (100%)

$8.5 (68.00%)

25

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMNM (Immunome ) average time for price targets to be met?

On average it took 87.4 days on average for the stock forecasts to be realized with a an average price target met ratio 46.67

Which analyst has the current highest performing score on IMNM (Immunome ) with a proven track record?

MATTHEW BARCUS

Which analyst has the current lower performing score on IMNM (Immunome ) with a proven track record?

BIREN AMIN

Which analyst has the most public recommendations on IMNM (Immunome )?

Matthew Barcus has 7 price targets and 4 ratings on IMNM

Which analyst is the currently most bullish on IMNM (Immunome )?

David Nierengarten with highest potential upside - $27.07

Which analyst is the currently most reserved on IMNM (Immunome )?

Matthew Barcus with lowest potential downside - $2.07

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?